share_log

Johnson & Johnson | 144: Notice of proposed sale of securities pursuant to Rule 144

Johnson & Johnson | 144: Notice of proposed sale of securities pursuant to Rule 144

强生 | 144:拟议出售证券
SEC announcement ·  03/13 16:33
Moomoo AI 已提取核心信息
Johnson & Johnson officer Vanessa Broadhurst is set to sell 8,891 shares of the company's common stock on 03/13/2024, with an aggregate market value of $1,441,731.66. The shares to be sold were acquired through restricted stock vesting under a registered plan on various dates, with the most recent acquisition of 199 shares on 02/13/2024. The securities were obtained as compensation from the issuer, Johnson & Johnson. There is no transaction history reported for the past three months prior to the notice date.
Johnson & Johnson officer Vanessa Broadhurst is set to sell 8,891 shares of the company's common stock on 03/13/2024, with an aggregate market value of $1,441,731.66. The shares to be sold were acquired through restricted stock vesting under a registered plan on various dates, with the most recent acquisition of 199 shares on 02/13/2024. The securities were obtained as compensation from the issuer, Johnson & Johnson. There is no transaction history reported for the past three months prior to the notice date.
强生公司高管凡妮莎·布罗德赫斯特定于2024年3月13日出售该公司8,891股普通股,总市值为1,441,731.66美元。待出售的股票是根据注册计划在不同日期通过限制性股票归属收购的,最近一次收购的199股股票是在2024年2月13日。这些证券是从发行人强生公司获得的补偿。在通知日期之前的过去三个月中,没有报告任何交易历史记录。
强生公司高管凡妮莎·布罗德赫斯特定于2024年3月13日出售该公司8,891股普通股,总市值为1,441,731.66美元。待出售的股票是根据注册计划在不同日期通过限制性股票归属收购的,最近一次收购的199股股票是在2024年2月13日。这些证券是从发行人强生公司获得的补偿。在通知日期之前的过去三个月中,没有报告任何交易历史记录。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息